These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 29047180)
1. Systematic screening of viral entry inhibitors using surface plasmon resonance. Kumar PKR Rev Med Virol; 2017 Nov; 27(6):. PubMed ID: 29047180 [TBL] [Abstract][Full Text] [Related]
2. Systematic Screening of Viral Entry Inhibitors Using Surface Plasmon Resonance. Kumar PKR Methods Mol Biol; 2020; 2089():131-145. PubMed ID: 31773651 [TBL] [Abstract][Full Text] [Related]
3. Screening of small-molecule compounds as inhibitors of HCV entry. Yang JP; Zhou D; Wong-Staal F Methods Mol Biol; 2009; 510():295-304. PubMed ID: 19009270 [TBL] [Abstract][Full Text] [Related]
4. Identification of pyrrolo[3,2-c]pyridin-4-amine compounds as a new class of entry inhibitors against influenza viruses in vitro. Chang SY; Cruz DJ; Ko Y; Min JY Biochem Biophys Res Commun; 2016 Sep; 478(4):1594-601. PubMed ID: 27586275 [TBL] [Abstract][Full Text] [Related]
5. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide. Kaneko M; Watashi K; Kamisuki S; Matsunaga H; Iwamoto M; Kawai F; Ohashi H; Tsukuda S; Shimura S; Suzuki R; Aizaki H; Sugiyama M; Park SY; Ito T; Ohtani N; Sugawara F; Tanaka Y; Mizokami M; Sureau C; Wakita T J Virol; 2015 Dec; 89(23):11945-53. PubMed ID: 26378168 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists. Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243 [TBL] [Abstract][Full Text] [Related]
8. A comparative high-throughput screening protocol to identify entry inhibitors of enveloped viruses. Wang J; Cheng H; Ratia K; Varhegyi E; Hendrickson WG; Li J; Rong L J Biomol Screen; 2014 Jan; 19(1):100-7. PubMed ID: 23821643 [TBL] [Abstract][Full Text] [Related]
9. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577 [TBL] [Abstract][Full Text] [Related]
10. Structure-based drug design for envelope protein E2 uncovers a new class of bovine viral diarrhea inhibitors that block virus entry. Pascual MJ; Merwaiss F; Leal E; Quintana ME; Capozzo AV; Cavasotto CN; Bollini M; Alvarez DE Antiviral Res; 2018 Jan; 149():179-190. PubMed ID: 29031833 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244 [TBL] [Abstract][Full Text] [Related]
12. Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors. Mittapalli GK; Jackson A; Zhao F; Lee H; Chow S; McKelvy J; Wong-Staal F; Macdonald JE Bioorg Med Chem Lett; 2011 Nov; 21(22):6852-5. PubMed ID: 21978675 [TBL] [Abstract][Full Text] [Related]
13. A cell-based high-throughput protocol to screen entry inhibitors of highly pathogenic viruses with Traditional Chinese Medicines. Yang Y; Cheng H; Yan H; Wang PZ; Rong R; Zhang YY; Zhang CB; Du RK; Rong LJ J Med Virol; 2017 May; 89(5):908-916. PubMed ID: 27704591 [TBL] [Abstract][Full Text] [Related]
14. Novel Small Molecule Entry Inhibitors of Ebola Virus. Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510 [TBL] [Abstract][Full Text] [Related]
15. Integrating surface plasmon resonance biosensor-based interaction kinetic analyses into the lead discovery and optimization process. Danielson UH Future Med Chem; 2009 Nov; 1(8):1399-414. PubMed ID: 21426056 [TBL] [Abstract][Full Text] [Related]
16. Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds. Tai CJ; Li CL; Tai CJ; Wang CK; Lin LT J Vis Exp; 2015 Oct; (105):e53124. PubMed ID: 26555014 [TBL] [Abstract][Full Text] [Related]
18. Strategies for antiviral screening targeting early steps of virus infection. Peng T Virol Sin; 2010 Aug; 25(4):281-93. PubMed ID: 20960301 [TBL] [Abstract][Full Text] [Related]
19. Blocking Respiratory Syncytial Virus Entry: A Story with Twists. Weisshaar M; Cox R; Plemper RK DNA Cell Biol; 2015 Aug; 34(8):505-10. PubMed ID: 25961744 [TBL] [Abstract][Full Text] [Related]
20. Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections. Sepúlveda-Crespo D; Ceña-Díez R; Jiménez JL; Ángeles Muñoz-Fernández M Med Res Rev; 2017 Jan; 37(1):149-179. PubMed ID: 27518199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]